Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.10%
SPX
+1.14%
IXIC
+1.39%
FTSE
+0.34%
N225
+1.30%
AXJO
-0.60%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
4.00B
Dividend Yield
0.00%
P/E Ratio
19.15
EPS
0.85
Revenue
426.45M
Avg. Volume
5.77M

Recently from Cashu

publisher logo
Cashu

Adma Biologics Enhances Immunotherapy Pipeline to Address Emerging Health Challenges

3 days ago
publisher logo
Cashu

Adma Biologics Focuses on Immunoglobulin Therapy Amid Market Optimism and Strategic Partnerships

5 days ago
publisher logo
Cashu

Adma Biologics: Pioneering Innovative Immunotherapy Solutions for Infectious Disease Treatment

7 days ago

About

What does ADMA do?
ADMA Biologics, headquartered in Ramsey, New Jersey, specializes in manufacturing FDA-approved plasma-derived biologics for immune deficiencies and infectious diseases, employing 624 staff. The company went public on October 17, 2013.
Sector
💻 Health Care
IPO
CEO
Employees
685
Headquarters
New Jersey, USA
Website
http://www.admabiologics.com
Stocks
Health Care
adma
Adma Biologics
NASDAQ: ADMA
+0.37 (+2.26%)
16.75
USD
At close at Aug 12, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials